While there was no significant association between SKP2 amplification and CRC risk in the amp v.s. del + wt model (amp v.s. del + wt model: OR = 0.33, 95% CI: 0.11, 1.02, P = 0.055). This evidence concerns the gene SKP2 and colorectal carcinoma.